dc.contributor.author | Kilic, Berkay | |
dc.contributor.author | Ozmen, Vahit | |
dc.contributor.author | Karanlik, Hasan | |
dc.contributor.author | Kuyumcu, Serkan | |
dc.contributor.author | Onder, Semen | |
dc.contributor.author | Has Simsek, Duygu | |
dc.contributor.author | Sanli, Yasemin | |
dc.contributor.author | Kuelle, Cemil B. | |
dc.date.accessioned | 2021-03-05T13:46:02Z | |
dc.date.available | 2021-03-05T13:46:02Z | |
dc.identifier.citation | Has Simsek D., Sanli Y., Kuelle C. B. , Karanlik H., Kilic B., Kuyumcu S., Onder S., Ozmen V., "Correlation of F-18-FDG PET/CT with pathological features and survival in primary breast cancer", NUCLEAR MEDICINE COMMUNICATIONS, cilt.38, ss.694-700, 2017 | |
dc.identifier.issn | 0143-3636 | |
dc.identifier.other | av_b3c2fac9-4c03-423e-89e3-6d24753c362f | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/119725 | |
dc.identifier.uri | https://doi.org/10.1097/mnm.0000000000000694 | |
dc.description.abstract | ObjectiveThe aim of this study was to determine the correlation between the primary tumor (PT) maximum standardized uptake value (SUVmax) and breast cancer prognostic factors, overall survival, and relapse-free survival on the basis of histopathological and molecular characteristics.Patients and methodsIn this retrospective study, 436 female patients with breast cancer were evaluated following a pretreatment F-18-FDG PET/CT scan. The PT SUVmax and histopathological/molecular characteristics were determined from primary tumor tissues and analyzed using the Mann-Whitney U and Kruskal-Wallis tests.ResultsThe median SUVmax of 436 PT was 10.1 (1.7-72). The PT SUVmax values were higher in ER- versus ER+ (P=0.001), PR- versus PR+ (P=0.001), Her2+ versus Her2- (P=0.01), Ki-67% of at least 20 versus Ki-67% of less than 20 (P<0.001), histological grade 3 versus grade 1-2 (P<0.001), nuclear pleomorphism score 3 versus score 1-2 (P<0.001), and mitotic score 3 versus score 1-2 patients (P<0.001). The lowest SUVmax levels were observed in the LumA group and the highest SUVmax levels were observed in the Her2 group (P<0.001). LumA patients with PR values greater than 20% had lower PT SUVmax values than the patients with PR values of 20% or less (P=0.023). The PT SUVmax was higher in patients with recurrence (P=0.03) and died related to disease (P<0.001) independent of time.ConclusionThe PT SUVmax showed a significant correlation with most of the prognostic factors and histopathological subtypes as a noninvasive tool. It is also usable in the prediction of tumor-related deaths or relapse independent of time. Our results could guide future studies to provide new histopathologic subtype definitions on the basis of new PR criteria. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nükleer Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME | |
dc.title | Correlation of F-18-FDG PET/CT with pathological features and survival in primary breast cancer | |
dc.type | Makale | |
dc.relation.journal | NUCLEAR MEDICINE COMMUNICATIONS | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.identifier.volume | 38 | |
dc.identifier.startpage | 694 | |
dc.identifier.endpage | 700 | |
dc.contributor.firstauthorID | 2502972 | |